7Baggers
 lantern pharma holds annual stockholders meeting  TipRanks Wed, 24 Sep 2025 01:46:04 GMT
 Lantern Pharma Holds Annual Stockholders Meeting  TipRanks Tue, 23 Sep 2025 07:00:00 GMT
 Lantern Pharma (LTRN) Advances LP-184 with Positive Phase 1a Tri  GuruFocus Tue, 16 Sep 2025 14:42:26 GMT
 Lantern Pharma announces LP-184 trial met all primary endpoints  TipRanks Tue, 16 Sep 2025 07:00:00 GMT
 Lantern Pharma receives FDA feedback on pediatric brain cancer trial  Investing.com Wed, 03 Sep 2025 07:00:00 GMT
 star tribune  FinancialContent Wed, 03 Sep 2025 07:00:00 GMT
 redchip to host exclusive investor webinar featuring lantern pharma on august 26  The Florida Times-Union Mon, 01 Sep 2025 05:38:48 GMT
 published on: 2025-08-29 04:29:23  Newser Fri, 29 Aug 2025 09:29:23 GMT
 published on: 2025-08-26 21:53:00  Newser Wed, 27 Aug 2025 02:53:00 GMT
 lantern pharma reports q2 2025 earnings and strategic progress  TipRanks Fri, 22 Aug 2025 04:01:09 GMT
 Lantern Pharma Reports Q2 2025 Earnings and Strategic Progress  TipRanks Thu, 21 Aug 2025 07:00:00 GMT

Lantern Pharma Inc
(NASDAQ:LTRN) 

LTRN stock logo

Lantern Pharma Inc., a clinical stage biotechnology company, focuses on the development of precision oncology therapies using artificial intelligence, genomics, and machine learning. Its advanced drug candidate is LP-100, which is in phase II clinical trials to treat metastatic, castration-resistant...

Founded: 2013
Full Time Employees: 4
CEO: Panna L. Sharma  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends